Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

astellas pharma ltd - tacrolimus monohydrate - granules - 1mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

astellas pharma ltd - mirabegron - modified-release tablet - 50mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

astellas pharma ltd - mirabegron - modified-release tablet - 25mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

astellas pharma ltd - enzalutamide - capsule - 40mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

astellas pharma ltd - solifenacin succinate; tamsulosin hydrochloride - modified-release tablet - 6mg ; 400microgram

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

astellas pharma (pty) ltd - capsules - see ingredients - each capsule contains enzalutamide 40,0 mg

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - tamsulosin hydrochloride 400ug;   - modified release tablet - 400 mcg - active: tamsulosin hydrochloride 400ug   excipient: hypromellose macrogol 7,000,000 (incl. 0.2mg butylated hydroxytoluene; 6.0mg collodial anhydrous silica) iron oxide yellow macrogol 8000   magnesium stearate

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 0.5mg - capsule - 0.5 mg - active: tacrolimus 0.5mg excipient: croscarmellose sodium gelatin hypromellose iron oxide yellow lactose monohydrate magnesium stearate purified water titanium dioxide - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 1mg - capsule - 1 mg - active: tacrolimus 1mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

research associates ltd - tacrolimus 5mg - capsule - 5 mg - active: tacrolimus 5mg excipient: croscarmellose sodium gelatin hypromellose iron oxide red lactose monohydrate magnesium stearate opacode white s-1-18086 titanium dioxide water - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidney-pancreas) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.